EDITOR IN CHIEF Alberto Corsini
Editorial Board Maurizio Averna Michel Farnier Meral Kayikcioglu Luis Masana Andrea Poli Evgeny V. Shlyakhto Margus Viigimaa
Editorial office Olga Brigida Elisa Gardini Angela Pirillo Roberto Zecca
Journal Manager Danilo Ruggeri
ISSN 2785-7115
Secretariat Via Balzaretti 7 20133 - Milano Invia email
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
|
The European Atherosclerosis Journal is a new international, peer-reviewed, fully open access, four-monthly journal covering all topics within atherosclerosis and cardiovascular disease areas. The Journal aims to publish high quality research and follows strict rules to assess originality and best practices for authorship and disclosure of potential conflicts of interest.
The European Atherosclerosis Journal is the international official journal of SITeCS (Italian Society for Experimental and Clinical Therapeutics).
European Atherosclerosis Journal is an international journal that publishes papers in the field of atherosclerosis and cardiovascular disease, from basic research to clinical and translational studies. Meta-analysis and systematic reviews will also be accepted. Papers will be considered for publication based on originality and contribution to the field. The journal will consider for publication original articles (experimental and clinical), review articles, methodology papers, editorials, letters to the Editor, viewpoints, congress/conference reports.
European Atherosclerosis Journal is published by SITeCS under a Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND) © The Author(s). Published by SITeCS Copyright retained by the author but commercial rights transferred to the publisher. For commercial re-use please contact the Editorial Office.
The Editorial Board invites you to submit a paper. European Atherosclerosis Journal - Guidelines for Authors in pdf format
Current issue:
• EAJ Vol 2, No 3 (2023) In this issue:
• |
Review Is there still a place for fenofibrate-statin combination therapy? Michel Farnier, Michal Vrablik, Alberico L. Catapano EAJ 2023;2:44-49
|
• |
|
• |
Congress/conference report - Selected Abstracts EAJ 2023;2:52-54
VLDL cholesterol associates with higher plasmatic expression of inflammatory proteins and atherosclerotic pathways compared to LDL cholesterol Elisa Mattavelli, Elena Olmastroni, Nick Nurmohamed, Liliana Grigore, Fabio Pellegatta, Erik S. G. Stroes, Alberico L. Catapano, Andrea Baragetti EAJ 2023;2:53
Different operational definitions of polypharmacy and their association with the risk of all-cause hospitalization: A conceptual framework using administrative databases Stefano Scotti, Elena Olmastroni, Federica Galimberti, Lorenza Scotti, Manuela Casula EAJ 2023;2:53-54
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease Marta Turri, Elisa Conti, Chiara Pavanello, Francesco Gastoldi, Marcella Palumbo, Franco Bernini, Vittoria Aprea, Francesca Re, Alberto Barbiroli, Davide Emide, Daniela Galimberti, Lucio Tremolizzo, Francesca Zimetti, Laura Calabresi EAJ 2023;2:52-53
Circulating plasma exosomes reflect the severity of myocardial damage in STEMI patients Marta Zarà, Andrea Baggiano, Patrizia Amadio, Jeness Campodonico, Sebastiano Gili, Andrea Annoni, Gianluca De Dona, Maria Ludovica Carerj, Francesco Cilia, Alberto Formenti, Laura Fusini, Cristina Banfi, Paola Gripari, Calogero Claudio Tedesco, Maria Elisabetta Mancini, Mattia Chiesa, Riccardo Maragna, Francesca Marchetti, Marco Penso, Luigi Tassetti, Alessandra Volpe, Alice Bonomi, Giancarlo Marenzi, Gianluca Pontone, Silvia Stella Barbieri EAJ 2023;2:52
|
|
|
|
Archives 2023
• EAJ Vol 2, No 2 (2023)
• EAJ Vol 2, No 1 (2023)
Archives 2022
• EAJ Vol 1, No 3 (2022) • EAJ Vol 1, No 2 (2022)
• EAJ Vol 1, No 1 (2022)
|